Whalerock Point Partners Decreased Gilead Sciences (GILD) Position by $470,375; Market Valuation Rose; 58 Com (WUBA) Stock Rose While Dragoneer Investment Group Lowered Its Stake

April 24, 2018 - By Adrian Erickson

Gilead Sciences, Inc. (NASDAQ:GILD) Logo

Whalerock Point Partners Llc decreased its stake in Gilead Sciences Inc (GILD) by 21.54% based on its latest 2017Q4 regulatory filing with the SEC. Whalerock Point Partners Llc sold 6,625 shares as the company’s stock rose 1.93% while stock markets declined. The institutional investor held 24,134 shares of the health care company at the end of 2017Q4, valued at $1.73M, down from 30,759 at the end of the previous reported quarter. Whalerock Point Partners Llc who had been investing in Gilead Sciences Inc for a number of months, seems to be less bullish one the $94.78B market cap company. The stock decreased 1.78% or $1.32 during the last trading session, reaching $72.69. About 2.67 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 9.79% since April 24, 2017 and is uptrending. It has underperformed by 1.76% the S&P500.

Dragoneer Investment Group Llc decreased its stake in 58 Com Inc (WUBA) by 20.36% based on its latest 2017Q4 regulatory filing with the SEC. Dragoneer Investment Group Llc sold 230,500 shares as the company’s stock rose 12.75% while stock markets declined. The institutional investor held 901,368 shares of the programming company at the end of 2017Q4, valued at $64.51M, down from 1.13M at the end of the previous reported quarter. Dragoneer Investment Group Llc who had been investing in 58 Com Inc for a number of months, seems to be less bullish one the $11.76 billion market cap company. The stock decreased 4.83% or $4.06 during the last trading session, reaching $80.01. About 1.13M shares traded or 5.41% up from the average. 58.com Inc. (NYSE:WUBA) has risen 114.05% since April 24, 2017 and is uptrending. It has outperformed by 102.50% the S&P500.

Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on May, 1 after the close. They expect $1.59 earnings per share, down 27.73% or $0.61 from last year’s $2.2 per share. GILD’s profit will be $2.07 billion for 11.43 P/E if the $1.59 EPS becomes a reality. After $1.60 actual earnings per share reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -0.63% negative EPS growth.

Whalerock Point Partners Llc, which manages about $651.31M and $315.86 million US Long portfolio, upped its stake in Cisco Systems Inc (NASDAQ:CSCO) by 14,750 shares to 58,030 shares, valued at $2.22M in 2017Q4, according to the filing. It also increased its holding in Blackstone Group Lp/The (NYSE:BX) by 11,700 shares in the quarter, for a total of 17,853 shares, and has risen its stake in Intel Corp (NASDAQ:INTC).

Investors sentiment decreased to 0.8 in 2017 Q4. Its down 0.23, from 1.03 in 2017Q3. It dived, as 95 investors sold GILD shares while 545 reduced holdings. 104 funds opened positions while 411 raised stakes. 972.68 million shares or 1.57% more from 957.62 million shares in 2017Q3 were reported. Welch Gru Lc has 3,728 shares for 0.04% of their portfolio. Supplemental Annuity Collective Tru Of Nj invested in 0.51% or 17,000 shares. United Automobile Association accumulated 0.28% or 1.42M shares. Convergence Invest Prtn Ltd Com holds 94,058 shares. Clark Estates New York holds 48,050 shares. Cap Guardian Trust Com holds 273,511 shares or 0.28% of its portfolio. Texas-based Amer Bank has invested 0.66% in Gilead Sciences, Inc. (NASDAQ:GILD). Vision Cap Mgmt has invested 1.15% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Ellington Mgmt Group Incorporated Limited Com has 5,900 shares. Capital Interest Sarl owns 0.23% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 33,700 shares. 6,097 were reported by Intersect Ltd Limited Liability Company. Moody Fincl Bank Division holds 0.03% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) for 9,013 shares. Old Bank In reported 29,470 shares stake. Penn Davis Mcfarland Inc accumulated 3.52% or 167,555 shares. American Cap Mngmt Inc holds 0.15% or 34,431 shares in its portfolio.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 126 analyst reports since July 29, 2015 according to SRatingsIntel. Cowen & Co maintained the shares of GILD in report on Tuesday, May 30 with “Buy” rating. Credit Suisse initiated it with “Outperform” rating and $125 target in Wednesday, January 20 report. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Neutral” rating given on Wednesday, February 8 by Citigroup. On Wednesday, December 20 the stock rating was downgraded by Credit Suisse to “Neutral”. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Buy” rating given on Thursday, August 31 by Argus Research. Leerink Swann maintained the shares of GILD in report on Thursday, October 19 with “Market Perform” rating. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Mkt Perform” rating given on Tuesday, September 27 by Leerink Swann. The stock has “Buy” rating by Needham on Wednesday, July 29. The firm has “Hold” rating by Credit Suisse given on Wednesday, January 3. Bank of America upgraded it to “Neutral” rating and $107 target in Monday, January 18 report.

Since January 2, 2018, it had 0 buys, and 18 insider sales for $39.95 million activity. 30,000 shares were sold by Alton Gregg H, worth $2.37M. MARTIN JOHN C also sold $4.18M worth of Gilead Sciences, Inc. (NASDAQ:GILD) shares. 60,000 shares were sold by WILSON GAYLE E, worth $4.68 million. Shares for $8.02M were sold by Meyers James R on Tuesday, January 16. 5,000 shares were sold by Washington Robin L, worth $401,566 on Wednesday, February 21.

Among 16 analysts covering 58.com (NYSE:WUBA), 8 have Buy rating, 3 Sell and 5 Hold. Therefore 50% are positive. 58.com had 26 analyst reports since August 21, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Friday, June 3 by Brean Capital. The rating was downgraded by HSBC on Tuesday, November 15 to “Hold”. As per Tuesday, August 8, the company rating was initiated by Citigroup. The rating was initiated by Deutsche Bank on Wednesday, October 5 with “Buy”. CLSA downgraded the shares of WUBA in report on Friday, November 11 to “Underperform” rating. The stock of 58.com Inc. (NYSE:WUBA) earned “Neutral” rating by Brean Capital on Friday, November 11. The stock of 58.com Inc. (NYSE:WUBA) earned “Hold” rating by Deutsche Bank on Wednesday, December 14. Morgan Stanley upgraded 58.com Inc. (NYSE:WUBA) on Tuesday, September 1 to “Overweight” rating. Morgan Stanley downgraded the stock to “Underweight” rating in Friday, June 30 report. The firm has “Outperform” rating given on Friday, May 26 by CLSA.

Gilead Sciences, Inc. (NASDAQ:GILD) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>